CLINICAL_TRIALS trial_result · 2016-12-30

Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis [Phase 2]

Phase 2 clinical trial evaluating safety, tolerability, and efficacy of AMG 827 in psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2016-12-30